This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Conrad Vink
Director, Vector Development, Cell & Gene Therapy at GSK


Conrad Vink leads the Vector Development team within GSK’s Cell & Gene Therapy group. The Vector Development team is responsible for the molecular biology and cell line development aspects of GSK’s lentiviral and AAV vector manufacturing processes. Prior to joining GSK Conrad did his PhD and postdoc in the design of lentiviral vectors for gene therapy at the Institute of Child Health, University College London

Agenda Sessions

  • Rapid generation of Lentiviral Vector Producer Cell Lines Using a Single DNA Construct


Speakers at this event